Frederic Zenhausern, Ph.D., MBA

ANBM’s Smart Shipping Incubator expedites the analysis of biospecimens, potentially cutting the processing time in half

Time and safety are essential when transporting human blood samples to laboratories for specialized analysis.

A new paper, “Automatic reagent handling and assay processing of human biospecimens inside a transportation container for a medical disaster response against radiation” — co-authored by Adam Akkad, Brett Duane, Jian Gu, PhD, Alan Norquist, and Frederic Zenhausern, PhD, MBA, of the University of Arizona College of Medicine – Phoenix’s Center for Applied NanoBioscience and Medicine (ANBM) — was published in Plos One… Continue reading.

Thanks to a U.S. Department of Defense contract for as much as $9.5 million, the University of Arizona College of Medicine – Phoenix and partners aim to develop a portable device to easily and accurately detects biological threats, including the virus that causes COVID-19.

To better protect those serving on the front lines of battlefields or dealing with an event like the COVID-19 health crisis or potential future pandemics, scientists at the University of Arizona College of Medicine – Phoenix are leading an effort to develop a device that could easily, quickly and accurately detect pathogens and biological threats.

The college’s Center for Applied Nanobioscience and Medicine is leading the effort, under an Other Transaction Agreement with the Defense Threat Reduction Agency, an agency within the U.S. Department of Defense. The contract, to provide about 3,000 devices, has a $9.5 million ceiling for three years.

Frederic Zenhausern, the center’s director and interim co-chair of the Department of Basic Medical Sciences, and his team members, including associate professor Jian Gu, are creating the device in collaboration with scientists from the University of Nevada, Arizona State University, Duke University and Whitespace Enterprises, an Arizona-based startup founded by Zenhausern. The group is responsible for mass production of the technology… Continue reading.

Researchers at the University of Arizona College of Medicine – Phoenix have developed a revolutionary “lung on a leaf” to study pulmonary diseases.

Kenneth Knox, MD, professor and associate dean of faculty affairs and development, and Frederic Zenhausern, PhD, MBA, professor and director of the UA Center for Applied NanoBioscience and Medicine, have received a three-year, $750,000 grant from the Arizona Biomedical Research Commission to study lung infections like Valley fever and inflammatory conditions like sarcoidosis in a plant model.

“The lung is a very complex organ,” Dr. Knox said. “There are not many novel ways to study the lung, but growing cells on a leaf would be a way for us to organize cell types in a biologically meaningful way to learn more about lung immunity and lung fibrosis… Continue reading.

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Frederic Zenhausern, Ph.D., MBA, Endowed Chair Professor, Basic Medical Sciences; Professor, Radiation Oncology; Director, Center for Applied Nanobioscience and Medicine; College of Medicine Phoenix, University of Arizona; Professor, Translational Genomics Research Institute; Director, Personalized Medicine Laboratory, Honor Health Research Institute;, Center for Applied Nanobioscience and Medicine, College of Medicine Phoenix, University of Arizona, to its College of Fellows. Dr. Zenhausern was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions as an interdisciplinary innovator, translating discoveries into product platforms to profoundly impact chemical analysis, forensics, and healthcare..